H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Psychology D-index 106 Citations 51,734 376 World Ranking 247 National Ranking 35
Medicine D-index 133 Citations 82,597 722 World Ranking 897 National Ranking 97

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Psychiatry

Dementia, Psychiatry, Parkinson's disease, Disease and Central nervous system disease are his primary areas of study. His Dementia research includes themes of Alzheimer's disease and Pediatrics. Dag Aarsland combines subjects such as Epidemiology, Clinical psychology and Rating scale with his study of Psychiatry.

The Parkinson's disease study combines topics in areas such as Apathy, Cognition, Rivastigmine and Parkinsonism. His work on Cognitive impairment as part of general Disease research is frequently linked to In patient, thereby connecting diverse disciplines of science. His studies in Central nervous system disease integrate themes in fields like Cross-sectional study, Physical therapy, Audiology and Atrophy.

His most cited work include:

  • Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium (3883 citations)
  • Clinical diagnostic criteria for dementia associated with Parkinson's disease. (1812 citations)
  • Clinical diagnostic criteria for dementia associated with Parkinson's disease. (1812 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Dementia, Disease, Psychiatry, Parkinson's disease and Dementia with Lewy bodies. His research integrates issues of Alzheimer's disease and Cognition in his study of Dementia. His Cognitive impairment study, which is part of a larger body of work in Disease, is frequently linked to In patient, bridging the gap between disciplines.

His Psychiatry study combines topics from a wide range of disciplines, such as Epidemiology and Pediatrics. As part of the same scientific family, Dag Aarsland usually focuses on Parkinson's disease, concentrating on Central nervous system disease and intersecting with Cognitive disorder. The various areas that Dag Aarsland examines in his Dementia with Lewy bodies study include Memantine and Neuroscience.

He most often published in these fields:

  • Dementia (87.89%)
  • Disease (56.26%)
  • Psychiatry (54.28%)

What were the highlights of his more recent work (between 2019-2021)?

  • Dementia (87.89%)
  • Disease (56.26%)
  • Cognitive decline (31.94%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Dementia, Disease, Cognitive decline, Cognition and Dementia with Lewy bodies. His studies deal with areas such as Psychiatry, Computational biology, Neuroscience and Gerontology as well as Dementia. His research in Psychiatry intersects with topics in Epidemiology and Cohort study.

His Disease study introduces a deeper knowledge of Internal medicine. His work investigates the relationship between Cognitive decline and topics such as Clinical psychology that intersect with problems in Anxiety, Apathy, Checklist and Confidence interval. His Cognition study integrates concerns from other disciplines, such as Longitudinal study, Functional decline, Parkinson's disease and Activities of daily living.

Between 2019 and 2021, his most popular works were:

  • Research criteria for the diagnosis of prodromal dementia with Lewy bodies (61 citations)
  • Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline. (27 citations)
  • Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline. (27 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Alzheimer's disease

Dag Aarsland spends much of his time researching Dementia, Disease, Dementia with Lewy bodies, Alzheimer's disease and Cohort. His work carried out in the field of Dementia brings together such families of science as Genome-wide association study, Neuroscience and Computational biology. His Disease research incorporates elements of Drug development, Clinical trial, Cognition and Gene.

His Dementia with Lewy bodies research is multidisciplinary, incorporating elements of Dopamine transporter and Audiology. The study incorporates disciplines such as Differential diagnosis, Cerebrospinal fluid and Neuroimaging in addition to Alzheimer's disease. His study with Psychosis involves better knowledge in Psychiatry.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium

I. G. McKeith;I. G. McKeith;D. W. Dickson;J. Lowe;M. Emre.
Neurology (2005)

4931 Citations

Clinical diagnostic criteria for dementia associated with Parkinson's disease.

Murat Emre;Dag Aarsland;Dag Aarsland;Richard Brown;David J. Burn.
Movement Disorders (2007)

2449 Citations

SeminarAlzheimer's disease

Clive Ballard;Serge Gauthier;Anne Corbett;Carol Brayne.
(2011)

1950 Citations

Diagnostic Criteria for Mild Cognitive Impairment in Parkinson’s Disease: Movement Disorder Society Task Force Guidelines

Irene Litvan;Jennifer G. Goldman;Alexander I. Tröster;Ben A. Schmand.
Movement Disorders (2012)

1774 Citations

Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

Dag Aarsland;Kjeld Andersen;Jan P Larsen;Anette Lolk.
JAMA Neurology (2003)

1676 Citations

Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium

Ian G. McKeith;Bradley F. Boeve;Dennis W. DIckson;Glenda Halliday.
Neurology (2017)

1504 Citations

Rivastigmine for Dementia Associated with Parkinson's Disease

Murat Emre;Dag Aarsland;Alberto Albanese;E. Jane Byrne.
The New England Journal of Medicine (2004)

1398 Citations

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

Niklas Mattsson;Henrik Zetterberg;Oskar Hansson;Niels Andreasen.
JAMA (2009)

1247 Citations

A systematic review of prevalence studies of dementia in Parkinson's disease.

Dag Aarsland;Dag Aarsland;Julia Zaccai;Carol Brayne.
Movement Disorders (2005)

1196 Citations

A systematic review of prevalence studies of depression in Parkinson's disease: The Prevalence of Depression in PD

Jennifer S.A.M. Reijnders;Uwe Ehrt;Wim E.J. Weber;Dag Aarsland.
Movement Disorders (2008)

1038 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Dag Aarsland

Kaj Blennow

Kaj Blennow

University of Gothenburg

Publications: 330

Henrik Zetterberg

Henrik Zetterberg

University of Gothenburg

Publications: 326

John T. O'Brien

John T. O'Brien

University of Cambridge

Publications: 230

Daniel Weintraub

Daniel Weintraub

University of Pennsylvania

Publications: 213

Philip Scheltens

Philip Scheltens

Vrije Universiteit Amsterdam

Publications: 199

John Q. Trojanowski

John Q. Trojanowski

University of Pennsylvania

Publications: 178

Daniela Berg

Daniela Berg

Kiel University

Publications: 176

David J. Burn

David J. Burn

Newcastle University

Publications: 169

Ian G. McKeith

Ian G. McKeith

Newcastle University

Publications: 142

John-Paul Taylor

John-Paul Taylor

Newcastle University

Publications: 141

Dennis W. Dickson

Dennis W. Dickson

Mayo Clinic

Publications: 138

Bradley F. Boeve

Bradley F. Boeve

Mayo Clinic

Publications: 130

Ronald C. Petersen

Ronald C. Petersen

Mayo Clinic

Publications: 124

Wiesje M. van der Flier

Wiesje M. van der Flier

Vrije Universiteit Amsterdam

Publications: 122

Alan J. Thomas

Alan J. Thomas

Newcastle University

Publications: 121

Frederik Barkhof

Frederik Barkhof

University College London

Publications: 117

Something went wrong. Please try again later.